Jupiter Neurosciences, Inc. (JUNS) — Financial statements
Income statement, balance sheet, and cash flow for Jupiter Neurosciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.02 | 0.00 | 0.00↓100.0% | 0.23↓63.4% | 0.64 | |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Gross Profit | 0.02 | 0.00 | 0.00↓100.0% | 0.23↓63.4% | 0.64 | |
| Operating Expenses | ||||||
| R&D Expenses | 2↑323.5% | 0.49↓48.4% | 0.95↑1.3% | 0.94↓34.9% | 1 | |
| General & Administrative Expenses | 7↑163.2% | 3↓10.9% | 3↑7.1% | 3↓12.1% | 3 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 7↑163.2% | 3↓10.9% | 3↑7.1% | 3↓12.1% | 3 | |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 9↑188.8% | 3↓20.1% | 4↑5.6% | 4↓19.3% | 5 | |
| Total Costs & Expenses | 9↑188.9% | 3↓20.1% | 4↑5.6% | 4↓19.3% | 5 | |
| Operating Results | ||||||
| Operating Income | -9↓188.2% | -3↑20.1% | -4↓12.8% | -3↑12.1% | -4 | |
| Depreciation & Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EBITDA | -9↓291.5% | -2↑52.0% | -5↓8.3% | -4↓3.2% | -4 | |
| EBIT | -9↓291.5% | -2↑52.0% | -5↓8.3% | -4↓3.2% | -4 | |
| Interest & Other Income | ||||||
| Net Interest Income | -0.07↑72.8% | -0.24↓11.3% | -0.22↑70.5% | -0.74↓550.1% | -0.11 | |
| Interest Income | 0.00↓100.0% | 0.01↑1052.9% | 0.00↓21.9% | 0.00↑367.4% | 0.00 | |
| Interest Expense | 0.07↓73.4% | 0.25↑13.6% | 0.22↓70.5% | 0.74↑549.9% | 0.11 | |
| Non-Operating Income | -0.33↑63.4% | -0.90↓229.6% | 0.69↓11.5% | 0.78↑337.7% | 0.18 | |
| Other Income / Expenses | 0.26↓59.5% | 0.65↑171.4% | -0.91↑40.1% | -2↓420.2% | -0.29 | |
| Income Before Tax | -9↓254.4% | -2↑49.0% | -5↑3.5% | -5↓18.0% | -4 | |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00↓100.0% | 0.18 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | -9↓254.4% | -2↑49.0% | -5↑3.5% | -5↓13.2% | -4 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | -9↓254.4% | -2↑49.0% | -5↑3.5% | -5↓13.2% | -4 | |
| Bottom-Line Net Income | -9↓254.4% | -2↑49.0% | -5↑3.5% | -5↓18.0% | -4 | |
| EPS (Basic) | -0.25↓194.8% | -0.08↑39.4% | -0.14↑6.7% | -0.15↑65.9% | -0.44 | |
| EPS (Diluted) | -0.25↓194.8% | -0.08↑39.4% | -0.14↑6.7% | -0.15↑65.9% | -0.44 | |
| Weighted Average Shares | 35↑20.3% | 29↓12.5% | 33↑0.0% | 33↑246.6% | 9 | |
| Weighted Average Diluted Shares | 35↑20.3% | 29↓12.5% | 33↑0.0% | 33↑246.6% | 9 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.